Clinical trial
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With…
NCT00416429 · Centre Leon Berard, Other · Completed
Key facts
| NCT number | NCT00416429 |
|---|---|
| Title | Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer |
| Official title | Medroxyprogesterone, Interferon Alpha-2a, Interleukin 2 or Combination of Both Cytokines in Patients With Metastatic Renal Carcinoma of Intermediate Prognosis [PERCY QUATTRO] |
| Lead sponsor | Centre Leon Berard, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, recombinant interferon alpha-2a, medroxyprogesterone |
| Enrollment | 456 |
| Completion | Feb 1, 2005 |
| First posted | Dec 28, 2006 |
| Last update posted | Sep 26, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: